Key Takeaways Access To GLP-1 Medications Has Expanded, Questions Remain The rapid growth of GLP-1 medications has transformed obesity treatment in the U.S., helping millions of patients access new weight-loss therapies. Yet despite a market projected to exceed $135 billion by 2030 and an expanding ecosystem of telehealth providers, about 40% of U.S. adults continue […]
Key Takeaways Access To GLP-1 Medications Has Expanded, Questions Remain The rapid growth of GLP-1 medications has transformed obesity treatment in the U.S., helping millions of patients access new weight-loss therapies. Yet despite a market projected to exceed $135 billion by 2030 and an expanding ecosystem of telehealth providers, about 40% of U.S. adults continue […]
